NEFL and metabolic disease: After excluding patients with metabolic diseases from the post-COVID group, a significant decrease was observed in NBD (P = 0.0002), NFA (P = 0.0001), NFD (P = 0.0001), NFL (P < 0.0001), and TBD (P = 0.0023).